KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $21.7 million.

  • Medpace Holdings' Tax Provisions rose 2867.65% to $21.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $91.3 million, marking a year-over-year increase of 2756.37%. This contributed to the annual value of $91.3 million for FY2025, which is 2756.37% up from last year.
  • Medpace Holdings' Tax Provisions amounted to $21.7 million in Q4 2025, which was up 2867.65% from $31.7 million recorded in Q3 2025.
  • In the past 5 years, Medpace Holdings' Tax Provisions registered a high of $34.3 million during Q2 2025, and its lowest value of $2.8 million during Q2 2021.
  • In the last 5 years, Medpace Holdings' Tax Provisions had a median value of $12.6 million in 2022 and averaged $13.7 million.
  • Its Tax Provisions has fluctuated over the past 5 years, first surged by 35926.6% in 2022, then tumbled by 6492.0% in 2025.
  • Medpace Holdings' Tax Provisions (Quarter) stood at $5.9 million in 2021, then fell by 15.49% to $5.0 million in 2022, then skyrocketed by 149.43% to $12.4 million in 2023, then skyrocketed by 35.9% to $16.9 million in 2024, then grew by 28.68% to $21.7 million in 2025.
  • Its Tax Provisions stands at $21.7 million for Q4 2025, versus $31.7 million for Q3 2025 and $34.3 million for Q2 2025.